医療ガバナンス研究所

Bhandari D, Ozaki A, Ghimire B, Sigdel S, Shrestha R, Pharm SSB, Pharm D, Higuchi A, Uprety A, Tsubokura M, Tanimoto T, Singh YP Oncology...

Yamamoto C, Sawano T, Nishikawa Y, Ozaki A, Shimada Y, Morita T, Zhao T, Hasegawa A, Oikawa T, Tsubokura M Evaluation of the emergency...

Moriyama N, Morita T, Nishikawa Y, Kobashi Y, Murakami M, Ozaki A, Nonaka S, Sawano T, Oikawa T, Tsubokura M Association of Living in...

Mizutani S, Takahashi K, Matsuura M Situation analyses of infant caregivers’ knowledge on liquid formula in Japan: A cross-sectional...

Ozaki A, Saito H, Sawano T, Shimada Y, Tanimoto T Accuracy of post-publication Financial Conflict of Interest corrections in medical...

Kidoguchi K, Mori J, Tanimoto T Idecabtagene Vicleucel in Relapsed Myeloma 2021/6/17

Uprety A, Kobashi Y, Ozaki A, Shrestha D, Ghimire B, Sedain G, Sigdel S, Higuchi A, Tsubokura M, Singh YP Awareness and Knowledge of the...

Kosaka M, Hashimoto T, Ozaki A, Tanimoto T, Kami M Delayed COVID-19 vaccine roll-out in Japan 2021/6/2

Nomura S, Murakami M, Ozaki A, Sawano T, Leppold C, Nishikawa Y, Saito H, Oikawa T, Tsubokura M Comparative risk assessment of...

Kobashi Y, Cheam S, Hayashi Y, Tsubokura M, Veyleang Ly, Noun C, Kozuma T, Buntongyi Nit, Okawada M Regional Differences in Admission...

Hashimoto T, Ozaki A, Tanimoto T Industry Payments to Medical Oncologists 2021/5/27

Shimazu Y, Kobashi Y, Zhao T, Nishikawa Y, Sawano T, Ozaki A, Obara D, Tsubokura M Mental distress in a clinical nurse due to a...

Bhandari D, Kotera Y, Ozaki A, Abeysinghe S, Kosaka M, Tanimoto T COVID-19: challenges faced by Nepalese migrants living in Japan 2021/4/19

Khatiwada AP, Shrestha S, Ozaki A, Shrestha R, Bhuvan KC Self-medication and masking of early cancer symptoms: is there a role for...

Sawano T, Shigetomi S, Ozaki A, Nishikawa Y, Hori A, Oikawa T, Maeda M, Tsubokura M Successful emergency evacuation from a hospital...

Murakami M, Takebayashi Y, Ono K, Tsubokura M Risk trade-off analysis of returning home and radiation exposure after a nuclear disaster...

Mousavi SH, Delshad MH, Martellucci CA, Bhandari D, Ozaki A, Pourhaji F, Pourhaji F, Hosseini SMR, Roien R, Ramozi AA, Wafaee M, Qaderi...

Tamaki T, Ozaki A, Sato H, Tsubokura M, Suzuki Y Alleviating the consequences of nuclear disasters on views on radiation risks among...

Shibusawa M, Tanimoto T Multiple myeloma triplet therapies: baseline characteristics and control groups 2021/5/1

Shibusawa M, Kidoguchi K, Mori J, Tanimoto T PET-guided omission of radiotherapy in Hodgkin lymphoma May, 2021